Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,659
archived clinical trials in
Metabolic

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Saint Thomas Hospital
mi
from
Nashville, TN
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Saint Thomas Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Baylor University Medical Center
mi
from
Dallas, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Cardiopulmonary Research Science & Technology Institute
mi
from
Dallas, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Cardiopulmonary Research Science & Technology Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Baptist Hospital Downtown
mi
from
San Antonio, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Baptist Hospital Downtown
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Renal Associates, PA
mi
from
San Antonio, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Renal Associates, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Clinical Research and Consulting Centter
mi
from
Fairfax, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Clinical Research and Consulting Centter
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
VCU Medical Center
mi
from
Richmond, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
VCU Medical Center
mi
from
Richmond, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Camc Institute
mi
from
Charleston, WV
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Camc Institute
mi
from
Charleston, WV
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Sarah S Olelewe MD
mi
from
Hawthorne, CA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Sarah S Olelewe MD
mi
from
Hawthorne, CA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Progressive Clinical Research
mi
from
Vista, CA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Progressive Clinical Research
mi
from
Vista, CA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Pikes Peak Cardiology
mi
from
Colorado Springs, CO
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Pikes Peak Cardiology
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Innovative Research of West FL
mi
from
Largo, FL
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Innovative Research of West FL
mi
from
Largo, FL
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Coastal Nephrology Assoc. Research Center
mi
from
Punta Gorda, FL
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Coastal Nephrology Assoc. Research Center
mi
from
Punta Gorda, FL
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Rockdale Medical Research Associates
mi
from
Conyers, GA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Rockdale Medical Research Associates
mi
from
Conyers, GA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Otis Barnum, DO
mi
from
Natchitoches, LA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Otis Barnum, DO
mi
from
Natchitoches, LA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Lillestol Research LLC
mi
from
Fargo, ND
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Lillestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Carolina Research Associates
mi
from
Columbia, SC
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Carolina Research Associates
mi
from
Columbia, SC
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Wayne O. Wells, MD
mi
from
Lebanon, TN
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Wayne O. Wells, MD
mi
from
Lebanon, TN
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Memorial Clinical Associates
mi
from
Houston, TX
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Memorial Clinical Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Mitchell Rosner, MD
mi
from
Charlottesville, VA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Mitchell Rosner, MD
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) Method
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the PDCAAS Method in the Bariatric Patient
Status: Enrolling
Updated:  7/22/2011
Southeast Bariatrics
mi
from
Charlotte, NC
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) Method
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the PDCAAS Method in the Bariatric Patient
Status: Enrolling
Updated: 7/22/2011
Southeast Bariatrics
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Currently Receiving Treatment With Elaprase®
Status: Enrolling
Updated:  10/6/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Currently Receiving Treatment With Elaprase®
Status: Enrolling
Updated: 10/6/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
Status: Enrolling
Updated:  2/27/2012
Wvu Department of Pediatrics
mi
from
Charleston, WV
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
Status: Enrolling
Updated: 2/27/2012
Wvu Department of Pediatrics
mi
from
Charleston, WV
Click here to add this to my saved trials
Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease
An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease
Status: Enrolling
Updated:  3/1/2012
ExSAR Corporation
mi
from
Monmouth Junction, NJ
Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease
An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease
Status: Enrolling
Updated: 3/1/2012
ExSAR Corporation
mi
from
Monmouth Junction, NJ
Click here to add this to my saved trials
Biotin Status in Pregnancy
Biotin Status in Pregnancy
Status: Enrolling
Updated:  7/24/2012
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Biotin Status in Pregnancy
Biotin Status in Pregnancy
Status: Enrolling
Updated: 7/24/2012
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
Decatur, GA
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
Newark, NJ
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
New York, NY
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
mi
from
Norfolk, VA
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Quick Start Insertion of Mirena and ParaGard
Quick Start Insertion of Mirena and ParaGard Intrauterine Contraceptive Devices
Status: Enrolling
Updated:  11/20/2012
Columbia University Medical Center
mi
from
New York, NY
Quick Start Insertion of Mirena and ParaGard
Quick Start Insertion of Mirena and ParaGard Intrauterine Contraceptive Devices
Status: Enrolling
Updated: 11/20/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
Status: Enrolling
Updated:  11/27/2012
Biofortis Clinical Research
mi
from
Addison, IL
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
Status: Enrolling
Updated: 11/27/2012
Biofortis Clinical Research
mi
from
Addison, IL
Click here to add this to my saved trials
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated:  12/10/2012
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated: 12/10/2012
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Vitamin D for Painful Nocturnal Leg Cramps
Nocturnal Leg Cramps in the Elderly: Randomized Controlled Trial of Ergocalciferol (Vitamin D2) for a Painful and Distressing Problem
Status: Enrolling
Updated:  1/14/2013
University of Wisconsin
mi
from
Madison, WI
Vitamin D for Painful Nocturnal Leg Cramps
Nocturnal Leg Cramps in the Elderly: Randomized Controlled Trial of Ergocalciferol (Vitamin D2) for a Painful and Distressing Problem
Status: Enrolling
Updated: 1/14/2013
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Status: Enrolling
Updated:  1/14/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Status: Enrolling
Updated: 1/14/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
Hospital for Special Surgery
mi
from
New York, NY
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Lovaza Mechanisms of Action
Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Status: Enrolling
Updated:  2/21/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Lovaza Mechanisms of Action
Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Status: Enrolling
Updated: 2/21/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
Children's Hospital and Research Center
mi
from
Oakland, CA
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Children's Hospital and Research Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Huntsville, AL
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Azusa, CA
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Azusa, CA
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otuska Investigational Site
mi
from
Orange, CA
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otuska Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Denver, CO
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Newark, DE
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Newark, DE
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Washington,
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
mi
from
Jacksonville, FL
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials